Somatic IL7R gain-of-function mutations were identified in around 10% of T-ALL cases and in B-ALL13,14, where they are enriched in particular subgroups, including Ph-like and PAX5 P80R B-ALL15–19. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.